Bio

Jeffrey Baumel co-heads the Firm's Life Sciences and Health Care industry sector and represents a broad range of companies in the life sciences, biotechnology and technology industries. His deep securities law experience comes from working with issuers, underwriters and venture capital investors on a wide range of transactions. These have included public offerings and private placements of equity and debt securities involving hundreds of millions of US dollars. In addition, Jeffrey has worked extensively with venture capital and investment banking firms specializing in growth-stage ventures.